Europe clears stroke treatment
This article was originally published in The Gray Sheet
Executive Summary
The Pharos stent, jointly developed and marketed with Biotronik AG to treat ischemic and hemorrhagic stroke, is CE marked March 8. Micrus Endovascular and Biotronik signed a pact in January to take Biotroniks' existing vascular technology and create new products for peripheral intervention...